Biologics Services

Passionate and dedicated, Frontage personnel deliver projects for a range of promising medicines, including vaccines, monoclonal antibodies, fusion proteins, protein-drug conjugates, and peptides.  We are also working with clients to ensure biosimilar product development results in drugs that are safe and effective.


While biologics offer tremendous promise, they can present more complexity than small molecule pharmaceuticals.   Clients seek our expertise in biologicals because we have consistently provided solutions that other contract researchers failed to find.


Experience the Frontage advantage by helping us learn more about your next project.  Together we can bring the next breakthrough biological to patients seeking a cure.


Supporting studies from drug discovery through clinical trials, Frontage provides a range of biologics services, including:

• Method development, transfer, and validation
• Nonclinical toxicokinetic (TK) studies
• Macromolecule PK/TK (hybridization and immunoassays)
• Immunogenicity assays (vaccine and anti-drug antibody assays)
• Neutralizing Antibody Assays (NAB)
• Cell Based Assays
• Biomarker services for drug development (i.e. PD, safety assessment, mechanism of action)
• And a range of other techniques for biologics development


Why Select Frontage for your Biologics Project?


You have certainly seen offers from, or worked with, other contract research organizations.  We’d like you to know that Frontage is different in the eyes of our clients.  For more than 10 years we’ve been solving the most complex drug development problems while sticking to our clients' budgets and meeting their aggressive timelines.  They’ve experienced project success in less time and at lower risk than they could have on their own, or with another research organization.

As the saying goes, “The proof is in the pudding.”  Today, more clients are bringing us more projects than ever before.  This has led to consistent records in annual growth.  To handle client needs, we’ve increased staff by nearly 300% in the past three years!  And we have plans to add more resources and further expand our service lines to accommodate the needs of pharmaceutical professionals just like you.  Tell us how we can move forward on your biologics project and bring soulutions that advance human health.  Thank You!